Literature DB >> 2536387

Evaluation of four methods for cytomegalovirus antibody detection for use by a bone marrow transplantation service.

D S Leland1, K A Barth, E B Cunningham, J Jansen, G J Tricot, M L French.   

Abstract

Four methods, latex agglutination, indirect fluorescent antibody, enzyme immunoassay, and complement fixation, were compared for cytomegalovirus antibody screening and for pre- and posttransplant determinations on bone marrow transplant recipients. Latex agglutination was most sensitive (98%) and specific (97%) for screening and pretransplant determinations and was quickest and easiest to perform. In posttransplant sera from allogeneic bone marrow transplant recipients, all methods except complement fixation detected cytomegalovirus antibody from therapeutically administered globulin preparations; this made it difficult to determine the significance of changes in cytomegalovirus antibody titer.

Mesh:

Substances:

Year:  1989        PMID: 2536387      PMCID: PMC267256          DOI: 10.1128/jcm.27.1.176-178.1989

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  15 in total

1.  Comparison of a latex agglutination test with five other methods for determining the presence of antibody against cytomegalovirus.

Authors:  D G Beckwith; D C Halstead; K Alpaugh; A Schweder; D A Blount-Fronefield; K Toth
Journal:  J Clin Microbiol       Date:  1985-03       Impact factor: 5.948

2.  Comparison of six methods for the detection of antibody to cytomegalovirus.

Authors:  T M McHugh; C H Casavant; J C Wilber; D P Stites
Journal:  J Clin Microbiol       Date:  1985-12       Impact factor: 5.948

3.  Detection of cytomegalovirus antibody with latex agglutination.

Authors:  S P Adler; M McVoy; V G Biro; W J Britt; P Hider; D Marshall
Journal:  J Clin Microbiol       Date:  1985-07       Impact factor: 5.948

4.  Cytomegalovirus antibody detection by three commercially available assays and complement fixation.

Authors:  D R Mayo; T Brennan; S P Sirpenski; C Seymour
Journal:  Diagn Microbiol Infect Dis       Date:  1985-09       Impact factor: 2.803

5.  Reactivity of serologic tests for the detection of antibody specific to cytomegalovirus. II. Latex agglutination and enzyme-linked immunosorbent assay.

Authors:  M LaRocco; J Mortenson; B G Davis; D G Moore
Journal:  Am J Clin Pathol       Date:  1986-09       Impact factor: 2.493

6.  Immunity to human cytomegalovirus measured and compared by complement fixation, indirect fluorescent-antibody, indirect hemagglutination, and enzyme-linked immunosorbent assays.

Authors:  J A Brandt; J D Kettering; J E Lewis
Journal:  J Clin Microbiol       Date:  1984-02       Impact factor: 5.948

7.  Comparison of five methods of cytomegalovirus antibody screening of blood donors.

Authors:  P H Phipps; L Grégoire; E Rossier; E Perry
Journal:  J Clin Microbiol       Date:  1983-12       Impact factor: 5.948

8.  Risk factors for cytomegalovirus infection after human marrow transplantation.

Authors:  J D Meyers; N Flournoy; E D Thomas
Journal:  J Infect Dis       Date:  1986-03       Impact factor: 5.226

9.  Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation.

Authors:  R A Bowden; M Sayers; N Flournoy; B Newton; M Banaji; E D Thomas; J D Meyers
Journal:  N Engl J Med       Date:  1986-04-17       Impact factor: 91.245

10.  Cytomegalovirus immune plasma in bone marrow transplant recipients.

Authors:  D J Winston; R B Pollard; W G Ho; J G Gallagher; L E Rasmussen; S N Huang; C H Lin; T G Gossett; T C Merigan; R P Gale
Journal:  Ann Intern Med       Date:  1982-07       Impact factor: 25.391

View more
  3 in total

1.  Results of a quality assurance program for detection of cytomegalovirus infection in the pediatric pulmonary and cardiovascular complications of vertically transmitted human immunodeficiency virus infection study.

Authors:  G J Demmler; A Istas; K A Easley; A Kovacs
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

2.  Evaluation of the CMV-CUBE assay for detection of cytomegalovirus serologic status in marrow transplant patients and marrow donors.

Authors:  C A Gleaves; S F Wendt; D R Dobbs; J D Meyers
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

3.  Evaluation of a latex particle agglutination assay for the detection of cytomegalovirus antibody in patient serum.

Authors:  D A Hursh; A D Abbot; R Sun; J P Iltis; D H Rice; C A Gleaves
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.